Gaussian Accelerated Molecular Dynamics Simulations Investigation on the Mechanism of Angiotensin-Converting Enzyme (ACE) C-Domain Inhibition by Dipeptides.
Congcong LiKaifeng LiuSiao ChenLu HanWeiwei HanPublished in: Foods (Basel, Switzerland) (2022)
Angiotensin-converting enzyme (ACE)-inhibitory peptides extracted from food proteins can lower blood pressure by inhibiting ACE activity. A recent study showed that the inhibitory activity of IY (Ile-Tyr, a dipeptide derived from soybean protein) against ACE was much higher than that of LL (Leu-Leu), although they had similar hydrophobic and predicted activity values. It was difficult to reveal the deep molecular mechanism underlying this phenomenon by traditional experimental methods. The Apo and two complex systems (i.e., ACE-LL and ACE-IY) were therefore subjected to 1 μs long Gaussian accelerated molecular dynamics (GaMD) simulations. The results showed that the binding of IY can cause obvious contraction of the active site of ACE, mainly manifested by a significant lateral shift of α13, α14, and α15. In addition, hinge 2 and hinge 3 were more stable in the ACE-IY system, while these phenomena were not present in the ACE-LL system. Moreover, the α10 of the IY-bound ACE kept an inward state during the simulation progress, which facilitated the ACE to remain closed. However, for the LL-bound ACE, the α10 switched between two outward states. To sum up, our study provides detailed insights into inhibitor-induced conformational changes in ACE that may help in the design of specific inhibitors targeting ACE for the treatment of hypertension.
Keyphrases
- angiotensin converting enzyme
- angiotensin ii
- molecular dynamics
- blood pressure
- molecular dynamics simulations
- adipose tissue
- dna methylation
- signaling pathway
- gene expression
- small molecule
- risk assessment
- cancer therapy
- endothelial cells
- single cell
- molecular docking
- weight loss
- insulin resistance
- dna binding
- single molecule
- combination therapy
- binding protein
- virtual reality